New Mexico
Register / Volume XXXVII, Issue 11 / June 9, 2026
NOTICE OF REGULAR
BOARD MEETING AND RULE HEARING
The New Mexico Board of Pharmacy will convene on July 16 and
17, 2026 at 9:00 a.m. and continue until finished in the Board of Pharmacy
Conference Room located at 5500 San Antonio Dr., NE, Albuquerque, NM 87109 for
the purpose of conducting a regular board meeting and rule hearing.
The agenda is posted 72 hours prior to the scheduled
meeting. You may view and download a
copy of the agenda through the board’s website:
https://www.rld.nm.gov/pharmacy/pharmacy-board-information/pharmacy-board-meetings/. All proposed
language regarding rule hearings is linked to the Agenda, the Notice to the
Public on our website and the New
Mexico Sunshine Portal.
Individuals petitioning the
board regarding requests/waivers must submit documentation for presentation;
via fax (505) 222-9845, mail or email to the Board Administrator, at the
general e-mail pharmacy.board@rld.nm.gov at least one week in advance of the
scheduled meeting.
Interested persons wishing to
comment on proposed language regarding rule hearings may submit documentation
for presentation prior to the hearing; via fax (505) 222-9845, mail or email to
the Board Administrator, at the general e-mail pharmacy.board@rld.nm.gov in
advance of the scheduled meeting. Public
comment is also allowed during the rule hearing.
If you are an individual with a
disability who is in need of a reader, amplifier,
qualified sign language interpreter, or any other form of auxiliary aid or
service, or if you are in need of a translator to
attend or participate in the hearing or meeting, please contact Board
Administrator at 505-222-9830 at least one week prior to the meeting or as soon
as possible. Public documents, including
the agenda and minutes, can be provided in various accessible formats. Please contact Board Administrator at 505-222-9830
or e-mail pharmacy.board@rld.nm.gov if a summary or other type of accessible
format is needed.
The full text of Proposed Rule Amendments for Rule Hearing
on July 16, 2026, at 9:10 a.m. is available for each rule via the hyperlinks
below, agenda hyperlinks, and Sunshine Portal notice hyperlinks. If you are unable to access the full text of
Proposed Rule Amendments via the links provided, please contact
pharmacy.board@rld.nm.gov for a copy.
Short explanation of the Purpose of Proposed Rule
Amendments: see below.
16.19.6 NMAC - PHARMACIES
Section 30, add allowance for a contracted pharmacy to
distribute repackaged dangerous drugs for medically monitored withdrawal
management or directly related supportive care to a custodial care facility
pursuant to 16.19.11.9 NMAC.
The purpose of the allowance is for availability of
unit-dose packaged drug stock at authorized custodial care facilities pursuant
to 16.19.11.9 NMAC.
STATUTORY AUTHORITY:
Paragraph (6) of Subsection A of Section 61-11-6 NMSA 1978 requires that
the board of Pharmacy provide for the licensing of retail pharmacies and
nonresident pharmacies and for the inspection of their facilities and
activities.
https://www.rld.nm.gov/wp-content/uploads/2026/05/pharm-16.19.6-NMAC-April-2026.pdf
16.19.10 NMAC - LIMITED DRUG CLINICS
Section 3, administrative updates and corrections.
Section 7, add definition of administer
Section 10, administrative updates, including replacing
should with shall throughout, for consistency and standard enforceability.
Section 11, public health clinics -Subsection A, correct
citation. Subsection B, consolidate
Paragraphs 1 and 2, renumber remainder.
Subsection D, Paragraph 1, add technician vaccine administration to
delineated activities and remove unnecessarily delineated activities of
medication counting, pouring, labeling and reconstitution. Paragraphs 2 and 3,
add technician vaccine administration rule citation. Subsection F, administrative updates and
remove requirement for repackaged drugs to be stored with manufacturer’s
package insert. Subsections K, L, M, N,
S, and T, administrative updates and spelling or language corrections.
Subsection 12, citation corrections.
The purpose of the proposed changes is to update, correct,
remove unnecessary provisions, and minimize administrative burden.
STATUTORY AUTHORITY:
Paragraph (6) of Subsection A of Section 61-11-6 NMSA 1978 requires the
Board of Pharmacy to provide for the licensing of industrial and public health
clinics and for the inspection of their facilities and activities. Pursuant to Paragraphs (6), (7), (8) and (12)
of Subsection B of Section 61-11-14 NMSA 1978, the Board is authorized to issue
drug permits, as defined and limited by Board regulation, for industrial health
clinics, community health clinics, and animal control facilities. Subsection (A) of Section 26-1-16 NMSA 1978
prohibits the sale, disposal or possession of any dangerous drug except by
individuals and entities identified in the statute, including clinics licensed
by the Board.
https://www.rld.nm.gov/wp-content/uploads/2026/05/pharm-16.019.10-Clean-NH.pdf
16.19.13 NMAC– TEMPORARY BUSINESS LICENSES
Sections 1 through 8, repeal and replace.
The purpose of the repeal and replace is to contemporize,
including citation corrections and provisions addressing non-resident
facilities.
STATUTORY AUTHORITY:
Paragraph 1 of Subsection B of Section 61-11-6 NMSA 1978 authorizes the
Board to delegate its authority to the Executive Director to issue temporary
licenses as provided in Subsection H of Section 61-11-14 NMSA 1978
https://www.rld.nm.gov/wp-content/uploads/2026/05/pharm-16.19.13-Repeal-Clean-NH-July-2026.pdf
Disciplinary Hearing(s):
Thursday July 16, 2026, 9:45 a.m. until 12:35 p.m. or until
finished, CasaPharma Rx, unlicensed, case 2026-015
Friday July 17, 2026, 9:10 a.m. until finished, Mike
Gallegos RP00006838, Complete Care Pharmacy LLC d/b/a Corrales Pharmacy
PH00004048, case 2024-051
If additional scheduling occurs, the final hearing date and
time for each case will be included in the agenda posted to the board’s website
at least 72 hours before the meeting.
Executive Director’s Report:
Published in NM Register:
June 9, 2026
Published in Albuquerque Journal: June 9, 2026